Review Papers Against Their Own Results

 Quick Explanation Copied

 Long Explanation

Evidence Behind the Review's Core Claims

This 2011 review from Kurume University (Kojima's group, who discovered ghrelin in 1999) synthesizes structural, regulatory, and functional evidence across species Sato et al. ghrelin structure review. Key reported findings: (1) the 28-aa mature peptide is encoded in exons 1–2; (2) des-acyl ghrelin cannot bind GHS-R nor release GH, yet induces food intake after intracerebroventricular injection, implying a non-GPCR mechanism the authors explicitly flag as unresolved; (3) acylation is essential for GH release and appetite stimulation; (4) the N-terminal 10 amino acids are identical across mammals, supporting their functional necessity. An earlier comprehensive review corroborated this multi-functional framing—GH release, appetite, metabolism, cardiovascular and reproductive roles—also acknowledging inconsistent acylated-vs-desacyl assay measurements and over-reliance on rodent models Korbonits et al. multi-function ghrelin review.

Cross-Species Conservation Data Reported in the Paper

The review reports these identity values and notes functional divergence: chicken ghrelin suppresses feeding in neonatal chicks (unlike mammals), and bullfrog ghrelin's Thr3 carries octanoyl or decanoyl modifications Sato et al. cross-species ghrelin data.

Critical Assessment and Blind Spots

What the review does well: authoritative provenance (JSPS/MEXT/Takeda funding disclosed; no commercial pharma sponsor listed Funding disclosures in ghrelin review), honest acknowledgment of open questions (des-acyl ghrelin mechanism), and comprehensive species coverage.

Blind spots and limitations: (a) It is a narrative review with no systematic search strategy, so citation bias is possible. (b) Knowledge half-life: GOAT was "recently identified" at writing; subsequent work (e.g., GLP-1R–mTORC1 suppression of ghrelin synthesis Exendin-4 mTOR ghrelin suppression study) postdates it, so regulatory-pathway coverage is now incomplete. (c) Rodent-to-human extrapolation pervades the field it summarizes. (d) Des-acyl ghrelin's receptor remains unidentified — the authors concede this, but the mechanism is still unresolved more than a decade later. (e) Clinical translation is thin; even later ghrelin-system reviews in oncology emphasize heterogeneous, inconclusive evidence Ghrelin system in breast cancer review.

Confidence note: The structural/evolutionary claims rest on strong primary purification and cloning data (high confidence). Claims about des-acyl ghrelin's central feeding effect are based on intracerebroventricular injections — pharmacologic, not physiological, evidence (moderate confidence). Disproving the review's framing would require identifying the des-acyl ghrelin receptor and showing GOAT-independent acylation pathways account for measurable acyl ghrelin in GOAT-deficient models.

 BGPT Paper Review

Study Novelty

A 2011 synthesis of an already-established hormone by its discoverers; the GOAT identification was recent then, but the review primarily consolidates rather than introduces new findings.

Scientific Quality

Authoritative group, well-organized, honest about unresolved mechanisms (des-acyl ghrelin receptor). Deductions: narrative format without systematic methods, and later work (GLP-1R/mTOR regulation) now supersedes parts of it.

Study Generality

Covers ghrelin biology across mammals, birds, amphibians, and fish, touching endocrinology, neuroscience, and metabolism broadly.

Study Usefulness

Excellent entry-point review for researchers entering ghrelin biology in 2011; still useful for structural/evolutionary background but dated on regulatory pathways and therapeutic implications.

Study Reproducibility

As a narrative review there are no methods or data to reproduce; however, the primary studies it summarizes (peptide purification, cloning, receptor assays) are classic and independently replicated.

Explanatory Depth

Explains structure-function relationships (Ser3 acylation, N-terminal conservation), gene architecture, and species-specific processing at mechanistic level, while candidly flagging unknowns like the des-acyl ghrelin receptor.